Trust Stamp announces allowance by the United States Patent and Trademark Office (“USPTO”) of a Non-Provisional Patent Application in respect of technology designed to identify deep fake and other Generative AI fuelled attacks in identity authentication processes 
Global Media First Drive of G700: A Comprehensive Validation of GAIA Hybrid Off-Road Architecture 
Scandium International Mining Announces Exercise of Options by Chief Executive Officer and Chief Financial Officer Trigone Pharma Announces the Initiation of a Phase 2 Clinical Trial of TRG-100 in Patients with Interstitial Cystitis/Bladder Pain Syndrome
TRG-100 is now being evaluated in broad range of bladder disorders RAANANA, Israel, Aug. 13,…
PMV Pharmaceuticals Reports Second Quarter 2021 Financial Results and Corporate Highlights
Continued enrollment in Phase 1/2 trial of first-in-class p53 Y220C reactivator PC14586 CRANBURY, N.J., Aug….
Alimera Sciences Announces Second Quarter 2021 Financial Results
Consolidated Net Revenue of $21.7 Million up 117% vs. Second Quarter of 2020 Consolidated Net…
Spectral Announces Second Quarter Results and Provides Corporate Update
TORONTO, Aug. 13, 2021 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:…
BioCardia to Participate in Upcoming Investor Conferences
SAN CARLOS, Calif., Aug. 13, 2021 (GLOBE NEWSWIRE) — BioCardia®, Inc. (Nasdaq: BCDA), a developer of…
Plus Therapeutics to Present Data from ReSPECT™-GBM Trial at the American Association of Neurological Surgeons 2021 Annual Scientific Meeting
AUSTIN, Texas, Aug. 13, 2021 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a…
Alpha Healthcare and Humacyte Announce Nominees for Election to Post-Merger Public Company Board of Directors
Nominees bring depth and diversity of scientific, commercial and financial experience to Board NEW YORK…
ContraFect Reports Second Quarter 2021 Financial Results and Provides Business Update
Multiple peer-reviewed journal publications and presentations at scientific forums drive value and recognition across the…
HCW Biologics Reports Second Quarter Financial Results and Recent Business Highlights
MIRAMAR, Fla., Aug. 13, 2021 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company”) (NASDAQ: HCWB),…
POINT Biopharma Reports Second Quarter 2021 Financial Results and Provides Business Update
Strengthened the Company’s balance sheet by completing the business combination with Therapeutics Acquisition Corp (“RACA”),…
Bio-Path Holdings Reports Second Quarter 2021 Financial Results
Conference Call to be Held Today at 8:30 A.M. ET HOUSTON, Aug. 13, 2021 (GLOBE…
Iterum Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update
–-Type A meeting with FDA expected late Q3 to define pathway to potential approval for…
Medicenna Reports First Quarter Fiscal 2022 Financial Results and Operational Highlights
— Phase 1/2 ABILITY Study of MDNA11 in patients with advanced solid tumors remains on…
Akero Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update
SOUTH SAN FRANCISCO, Calif., Aug. 13, 2021 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO), a cardio-metabolic biotechnology…
23andMe Reports FY2022 First Quarter Financial Results
First quarter revenue up 23% over prior yearStrong cash balance of $770 millionContinuing to advance…
Longeveron Inc. Provides Corporate Update and Reports Second Quarter 2021 Financial Results
Longeveron to hold conference call today at 8:00 AM EDT MIAMI, Aug. 13, 2021 (GLOBE…
Trillium Therapeutics Reports Second Quarter 2021 Operating and Financial Results
CAMBRIDGE, Mass., Aug. 13, 2021 (GLOBE NEWSWIRE) — Trillium Therapeutics Inc. (NASDAQ/TSX: TRIL), a clinical stage…
Longeveron Announces Topline Results of Phase 2b Study of Lomecel-B for Aging Frailty
— Study meets one of the two analyses of primary efficacy endpoint: statistically significant dose-response…
Freeline Provides Executive Leadership Team Update; Company to Provide Corporate Update and Second Quarter 2021 Financial Results on Monday, August 16
Guidance across all programs remains unchanged for expected data and clinical development milestones in 2021…
CytoDyn Receives FDA Guidance for its HIV BLA Dose Justification Report
Company Believes All Issues Are Addressable and it Will Be Able to Continue BLA Resubmission…